El papel del antígeno prostático específico (PSA) y el estadio patológico antes de la radioterapia en la predicción de los resultados de la resonancia magnética multiparamétrica (RMmp) en pacientes con recidiva del cancer de próstata tras prostatectomía radical
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
El papel del antígeno prostático específico (PSA) y el estadio patológico antes de la radioterapia en la predicción de los resultados de la resonancia magnética multiparamétrica (RMmp) en pacientes con recidiva del cancer de próstata tras prostatectomía radical
Authors
Keywords
-
Journal
Actas Urologicas Espanolas
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-09
DOI
10.1016/j.acuro.2023.07.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade
- (2021) Aradhana M. Venkatesan et al. CANCER IMAGING
- Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI
- (2019) D.Y. Chung et al. EUROPEAN UROLOGY SUPPLEMENTS
- Prostate MR Imaging for Posttreatment Evaluation and Recurrence
- (2018) Sonia Gaur et al. RADIOLOGIC CLINICS OF NORTH AMERICA
- Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer
- (2018) Cristina Dominguez et al. International Braz J Urol
- What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel
- (2017) Paul C. Moldovan et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
- (2017) Philip Cornford et al. EUROPEAN UROLOGY
- Detection of Local Recurrence of Prostate Cancer After Radical Prostatectomy Using Endorectal Coil MRI at 3 T: Addition of DWI and Dynamic Contrast Enhancement to T2-Weighted MRI
- (2015) Kazuhiro Kitajima et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
- (2015) Jurgen J. Fütterer et al. EUROPEAN UROLOGY
- The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
- (2015) Stacy Loeb et al. JOURNAL OF UROLOGY
- Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images
- (2015) M Abd-Alazeez et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging
- (2013) Valeria Panebianco et al. EUROPEAN RADIOLOGY
- An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011
- (2012) John B. Eifler et al. BJU INTERNATIONAL
- Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer
- (2012) Andrea Alfarone et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil
- (2012) Hans Christian Rischke et al. Radiation Oncology
- Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
- (2011) Scott E. Eggener et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More